These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2979821

  • 1. On the origin and control of C3NeF.
    Spitzer RE, Stitzel AE.
    In Vivo; 1988; 2(1):79-81. PubMed ID: 2979821
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity.
    Spitzer RE, Stitzel AE, Tsokos GC.
    J Immunol; 1992 Jan 01; 148(1):137-41. PubMed ID: 1727863
    [Abstract] [Full Text] [Related]

  • 3. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD.
    Nephrol Dial Transplant; 1994 Jan 01; 9(7):811-4. PubMed ID: 7970124
    [Abstract] [Full Text] [Related]

  • 4. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 5. Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.
    Spitzer RE, Stitzel AE, Tsokos GC.
    Clin Immunol Immunopathol; 1990 Oct 15; 57(1):10-8. PubMed ID: 1697516
    [Abstract] [Full Text] [Related]

  • 6. Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.
    Spitzer RE, Stitzel AE, Tsokos GC.
    J Pediatr; 1990 May 15; 116(5):S103-8. PubMed ID: 2329411
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nucleotide sequence of a human autoantibody to the alternative pathway C3/C5 convertase (C3NeF).
    Victor KD, Pascual V, Stitzel AE, Tsokos GC, Capra JD, Spitzer RE.
    Hybridoma; 1993 Jun 15; 12(3):231-7. PubMed ID: 8395463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.
    Tsokos GC, Stitzel AE, Patel AD, Hiramatsu M, Balow JE, Spitzer RE.
    Clin Immunol Immunopathol; 1989 Oct 15; 53(1):113-22. PubMed ID: 2475285
    [Abstract] [Full Text] [Related]

  • 12. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug 15; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 13. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
    Ohi H, Yasugi T.
    Clin Exp Immunol; 1994 Feb 15; 95(2):316-21. PubMed ID: 8306508
    [Abstract] [Full Text] [Related]

  • 14. Study of the idiotypic response to autoantibody to the alternative pathway C3/C5 convertase in normal individuals, patients with membranoproliferative glomerulonephritis, and experimental animals.
    Spitzer RE, Stitzel AE, Tsokos GC.
    Clin Immunol Immunopathol; 1992 Mar 15; 62(3):291-4. PubMed ID: 1541054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.
    Frémeaux-Bacchi V, Weiss L, Demouchy C, May A, Palomera S, Kazatchkine MD.
    Nephrol Dial Transplant; 1994 Mar 15; 9(12):1747-50. PubMed ID: 7708258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significance of C3 nephritic factor (C3NeF) in non-hypocomplementaemic serum with membranoproliferative glomerulonephritis (MPGN).
    Ohi H, Watanabe S, Fujita T, Yasugi T.
    Clin Exp Immunol; 1992 Sep 15; 89(3):479-84. PubMed ID: 1516262
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep 15; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 20. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb 15; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.